Biofarm S.A. (BVB:BIO)

Romania flag Romania · Delayed Price · Currency is RON
1.295
+0.020 (1.57%)
At close: Feb 27, 2026
82.91%
Market Cap 1.28B
Revenue (ttm) 318.89M
Net Income (ttm) 88.21M
Shares Out 985.37M
EPS (ttm) 0.08
PE Ratio 15.92
Forward PE n/a
Dividend 0.03 (2.41%)
Ex-Dividend Date Aug 18, 2025
Volume 178,424
Average Volume 165,403
Open 1.270
Previous Close 1.275
Day's Range 1.250 - 1.295
52-Week Range 0.620 - 1.355
Beta 0.42
RSI 72.02
Earnings Date Feb 27, 2026

About Biofarm

Biofarm S.A. manufactures and sells medicines in Romania. The company offers a portfolio of products covering therapeutic areas, such as antiallergics, cardiovascular and circulatory, analgesics and antipyretics, dermatology, digestive and metabolic, endocrine, genitourinary, multivitamins, ophthalmology, musculoskeletal, respiratory and ENT, and neurology. It provides prescription and non-prescription medicines, food supplements, medical devices, cosmetics, and other products. The company also exports its products in Azerbaijan, Albania, Georg... [Read more]

Industry Pharmaceutical Preparations
Founded 1921
Employees 367
Stock Exchange Bucharest Stock Exchange
Ticker Symbol BIO
Full Company Profile

Financial Performance

In 2024, Biofarm's revenue was 286.77 million, an increase of 2.31% compared to the previous year's 280.29 million. Earnings were 74.40 million, a decrease of -3.40%.

Financial Statements

News

There is no news available yet.